The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death

EMBO J. 2000 Jun 15;19(12):2958-68. doi: 10.1093/emboj/19.12.2958.

Abstract

Evi-1 encodes a nuclear protein involved in leukemic transformation of hematopoietic cells. Evi-1 possesses two sets of zinc finger motifs separated into two domains, and its characteristics as a transcriptional regulator have been described. Here we show that Evi-1 acts as an inhibitor of c-Jun N-terminal kinase (JNK), a class of mitogen-activated protein kinases implicated in stress responses of cells. Evi-1 physically interacts with JNK, although it does not affect its phosphorylation. This interaction is required for inhibition of JNK. Evi-1 protects cells from stress-induced cell death with dependence on the ability to inhibit JNK. These results reveal a novel function of Evi-1, which provides evidence for inhibition of JNK by a nuclear oncogene product. Evi-1 blocks cell death by selectively inhibiting JNK, thereby contributing to oncogenic transformation of cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Biological
  • Apoptosis*
  • Cell Transformation, Neoplastic*
  • DNA-Binding Proteins / metabolism*
  • Humans
  • JNK Mitogen-Activated Protein Kinases
  • MDS1 and EVI1 Complex Locus Protein
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinases / metabolism
  • Protein Binding
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogenes*
  • Signal Transduction
  • Transcription Factor AP-1 / metabolism
  • Transcription Factors*
  • Transcription, Genetic
  • Zinc Fingers

Substances

  • DNA-Binding Proteins
  • MDS1 and EVI1 Complex Locus Protein
  • MECOM protein, human
  • Proto-Oncogene Proteins
  • Transcription Factor AP-1
  • Transcription Factors
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases